
(R)-(-)-Rolipram
CAS No. 85416-75-7
(R)-(-)-Rolipram( R)-Rolipram | (-)-Rolipram )
Catalog No. M16203 CAS No. 85416-75-7
A more active enantiomer of the PDE4 inhibitor rolipram.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 35 | Get Quote |
![]() ![]() |
5MG | 56 | Get Quote |
![]() ![]() |
10MG | 88 | Get Quote |
![]() ![]() |
25MG | 170 | Get Quote |
![]() ![]() |
50MG | 317 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product Name(R)-(-)-Rolipram
-
NoteResearch use only, not for human use.
-
Brief DescriptionA more active enantiomer of the PDE4 inhibitor rolipram.
-
DescriptionA more active enantiomer of the PDE4 inhibitor rolipram; shows 2-10-fold more potent than the S-(+) enantiomer rolipram.Asthma Phase 2 Clinical.
-
In VitroThe increase of cAMP synthesis with the adenylate cyclase activator forskolin or the decrease of cAMP hydrolysis by the phosphodiesterase inhibitors Isobutylmethylxanthine (IBMX) and (R)-(-)-Rolipram suppresses caspase-1 cleavage and IL-1β secretion in a dose-dependent manner.
-
In Vivo——
-
SynonymsR)-Rolipram | (-)-Rolipram
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research AreaInflammation/Immunology
-
IndicationAsthma
Chemical Information
-
CAS Number85416-75-7
-
Formula Weight275.3428
-
Molecular FormulaC16H21NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 49 mg/mL
-
SMILESCOC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3
-
Chemical Name2-Pyrrolidinone, 4-[3-(cyclopentyloxy)-4-methoxyphenyl]-, (4R)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Schneider HH, et al. Eur J Pharmacol. 1986 Aug 7;127(1-2):105-15.
2. Owens RJ, et al. Biochem J. 1997 Aug 15;326 ( Pt 1):53-60.
3. Ohsawa F, et al. Jpn J Pharmacol. 1998 Jun;77(2):147-54.
molnova catalog



related products
-
ITI214
ITI-214 is a potent, selective, orally active phosphodiesterase 1 (PDE1) inhibitor with Ki of 58 pM.
-
Oglemilast
Oglemilast (GRC-3886) is a potent and selective PDE4 inhibitor with IC50 of 2.5 and 1.7 nM for PDE4B and PDE4D, respectively.
-
Lotamilast
Lotamilast (RVT 501, E6005) is a?potent, selective PDE4 inhibitor with IC50 of 2.8 nM, suppresses the production of various cytokines from human lymphocytes and monocytes with IC50 of 0.49-3.1 nM.